|
Q
|
Colcr5
|
Colorectal carcinoma resistance QTL 5
|
|
IDA
|
| 9.0E-4 |
3.18
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:98,944,780...143,944,780
|
|
Q
|
Colcr9
|
Colorectal carcinoma resistance QTL 9
|
|
IDA
|
| 0.0024 |
2.97
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr20:1...33,724,594
|
|
|
Q
|
Colcr1
|
Colorectal carcinoma resistance QTL 1
|
|
IDA
|
| 3.0E-4 |
4.3
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 4:8,428,551...30,449,094
|
|
Q
|
Colcr6
|
Colorectal carcinoma resistance QTL 6
|
|
IDA
|
| 0.0126 |
2.9
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:83,700,787...108,192,169
|
|
Q
|
Colcr7
|
Colorectal carcinoma resistance QTL 7
|
|
IDA
|
| 0.0044 |
3.35
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr17:2,120,843...22,087,569
|
|
Q
|
Colcs1
|
Colorectal carcinoma susceptibility QTL 1
|
|
IDA
|
| 0.0055 |
2.99
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 5:160,071,170...172,129,029
|
|
|
Q
|
Colcr2
|
Colorectal carcinoma resistance QTL 2
|
|
IDA
|
| 0.0197 |
6.57
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:2,315,759...47,315,759
|
|
|
Q
|
Mamtr7
|
Mammary tumor resistance QTL 7
|
|
IDA
|
| 0.003 |
|
|
RGD |
PMID:19052818 |
RGD:2302423 |
|
|
Q
|
Mamtr8
|
Mammary tumor resistance QTL 8
|
|
IDA
|
| 0.001 |
|
|
RGD |
PMID:19052818 |
RGD:2302423 |
NCBI chr18:31,610,505...85,493,247
|
|
Q
|
Mcs20
|
Mammary carcinoma susceptibility QTL 20
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 9:21,031,430...49,025,574
|
|
Q
|
Mcs21
|
Mammary carcinoma susceptibility QTL 21
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr10:29,377,046...52,699,134
|
|
Q
|
Mcs22
|
Mammary carcinoma susceptibility QTL 22
|
|
IDA
|
| |
3.3
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
|
|
|
Q
|
Mcs31
|
Mammary carcinoma susceptibility QTL 31
|
|
IDA
|
| |
2.98
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 9:85,262,459...118,999,486
|
|
Q
|
Mcs32
|
Mammary carcinoma susceptibility QTL 32
|
|
IDA
|
| |
2.61
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
|
|
Q
|
Mcs33
|
Mammary carcinoma susceptibility QTL 33
|
|
IDA
|
| |
1.93
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr 5:136,631,198...172,190,305
|
|
Q
|
Mcs34
|
Mammary carcinoma susceptibility QTL 34
|
|
IDA
|
| |
1.54
|
|
RGD |
PMID:23967281 |
RGD:7794780 |
NCBI chr18:65,635,567...85,897,775
|
|
|
Q
|
Emca11
|
Estrogen-induced mammary cancer QTL 11
|
|
IDA
|
| |
|
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:73,176,602...118,176,602
|
|
Q
|
Emca12
|
Estrogen-induced mammary cancer QTL 12
|
|
IDA
|
| |
|
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:94,034,903...139,034,903
|
|
Q
|
Emca13
|
Estrogen-induced mammary cancer QTL 13
|
|
IDA
|
| |
|
|
RGD |
PMID:23151807 |
RGD:7364727 |
NCBI chr 5:14,606,078...59,606,078
|
|
Q
|
Emca6
|
Estrogen-induced mammary cancer QTL 6
|
|
IDA
|
| |
5.8
|
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 4:45,429,709...157,555,683
|
|
Q
|
Emca7
|
Estrogen-induced mammary cancer QTL 7
|
|
IDA
|
| |
4.0
|
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 6:20,859,430...113,082,285
|
|
Q
|
Emca8
|
Estrogen-induced mammary cancer QTL 8
|
|
IDA
|
| |
4.1
|
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 5:55,124,766...172,190,305
|
|
Q
|
Mamtr1
|
Mammary tumor resistance QTL 1
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:12844486 |
RGD:631852 |
NCBI chr 5:17,576,633...62,576,633
|
|
Q
|
Mamtr2
|
Mammary tumor resistance QTL 2
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:9,623,581...54,623,581
|
|
Q
|
Mamtr3
|
Mammary tumor resistance QTL 3
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:14522903 |
RGD:724790 |
|
|
Q
|
Mamtr4
|
Mammary tumor resistance QTL 4
|
|
IDA
|
| 3.0E-4 |
|
|
RGD |
PMID:14522903 |
RGD:724790 |
NCBI chr 2:18,227,137...63,227,137
|
|
Q
|
Mamtr5
|
Mammary tumor resistance QTL 5
|
|
IDA
|
| |
|
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr 5:23,671,493...68,671,493
|
|
Q
|
Mamtr6
|
Mammary tumor resistance QTL 6
|
|
IDA
|
| |
|
|
RGD |
PMID:17230524 |
RGD:1599390 |
NCBI chr18:19,553,532...85,493,247
|
|
Q
|
Mcs1
|
Mammary carcinoma susceptibility QTL 1
|
|
IDA
|
| |
4.4
|
|
RGD |
PMID:8168109 |
RGD:61080 |
NCBI chr 2:9,623,581...25,054,526
|
|
Q
|
Mcs12
|
Mammary carcinoma susceptibility QTL 12
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:16266982 |
RGD:1559294 |
|
|
Q
|
Mcs13
|
Mammary carcinoma susceptibility QTL 13
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:16266982 |
RGD:1559294 |
|
|
Q
|
Mcs14
|
Mammary carcinoma susceptibility QTL 14
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:16266982 |
RGD:1559294 |
|
|
Q
|
Mcs15
|
Mammary carcinoma susceptibility QTL 15
|
|
IDA
|
| |
4.5
|
|
RGD |
PMID:16568087 |
RGD:1581951 |
NCBI chr10:72,724,423...107,713,808
|
|
Q
|
Mcs16
|
Mammary carcinoma susceptibility QTL 16
|
|
IDA
|
| |
2.4
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:1...26,564,886
|
|
Q
|
Mcs17
|
Mammary carcinoma susceptibility QTL 17
|
|
IDA
|
| |
3.0
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 1:207,099,883...252,099,883
|
|
Q
|
Mcs18
|
Mammary carcinoma susceptibility QTL 18
|
|
IDA
|
| |
2.6
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 2:9,623,581...44,538,110
|
|
Q
|
Mcs19
|
Mammary carcinoma susceptibility QTL 19
|
|
IDA
|
| |
2.5
|
|
RGD |
PMID:16596452 |
RGD:1599317 |
NCBI chr 5:82,032,155...127,032,155
|
|
Q
|
Mcs2
|
Mammary carcinoma susceptibility QTL 2
|
|
IDA
|
| |
3.38
|
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 7:20,920,494...37,412,865
|
|
Q
|
Mcs23
|
Mammary carcinoma susceptibility QTL 23
|
|
IDA
|
| |
|
|
RGD |
PMID:17404222 |
RGD:1601189 |
|
|
Q
|
Mcs24
|
Mammary carcinoma susceptibility QTL 24
|
|
IDA
|
| |
|
|
RGD |
PMID:17404222 |
RGD:1601189 |
NCBI chr 5:69,835,120...114,835,120
|
|
Q
|
Mcs28
|
Mammary carcinoma susceptibility QTL 28
|
|
IDA
|
| |
|
|
RGD |
PMID:21205740 |
RGD:5684388 |
|
|
Q
|
Mcs29
|
Mammary carcinoma susceptibility QTL 29
|
|
IDA
|
| |
|
|
RGD |
PMID:21205740 |
RGD:5684388 |
NCBI chr 5:38,004,331...83,004,331
|
|
Q
|
Mcs3
|
Mammary carcinoma susceptibility QTL 3
|
|
IDA
|
| |
2.15
|
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 1:111,404,407...142,582,336
|
|
Q
|
Mcs30
|
Mammary carcinoma susceptibility QTL 30
|
|
IDA
|
| |
8.62
|
|
RGD |
PMID:24023717 |
RGD:7327193 |
NCBI chr12:5,633,306...50,633,306
|
|
Q
|
Mcs4
|
Mammary carcinoma susceptibility QTL 4
|
|
IDA
|
| |
1.1
|
|
RGD |
PMID:9584103 |
RGD:61081 |
NCBI chr 8:44,475,043...89,475,043
|
|
Q
|
Mcs5
|
Mammary carcinoma susceptibility QTL 5
|
|
IDA
|
| |
10.51
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 5:60,601,597...137,492,949
|
|
Q
|
Mcs6
|
Mammary carcinoma susceptibility QTL 6
|
|
IDA
|
| |
2.29
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 7:28,624,575...65,788,017
|
|
Q
|
Mcs7
|
Mammary carcinoma susceptibility QTL 7
|
|
IDA
|
| |
2.38
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr10:72,724,423...107,713,808
|
|
Q
|
Mcs8
|
Mammary carcinoma susceptibility QTL 8
|
|
IDA
|
| |
4.28
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr14:3,957,878...24,886,169
|
|
Q
|
Mcsm1
|
Mammary carcinoma susceptibility modifier QTL 1
|
|
IDA
|
| |
|
|
RGD |
PMID:11139513 |
RGD:62417 |
NCBI chr 6:64,367,996...109,367,996
|
|
|
Q
|
Tcas10
|
Tongue tumor susceptibility QTL 10
|
|
IDA
|
| |
3.12
|
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr10:31,796,281...76,796,281
|
|
Q
|
Tcas11
|
Tongue tumor susceptibility QTL 11
|
|
IDA
|
| |
4.12
|
|
RGD |
PMID:16527513 |
RGD:1578522 |
NCBI chr 5:51,657,967...166,600,247
|
|
Q
|
Tcas2
|
Tongue tumor susceptibility QTL 2
|
|
IDA
|
| |
4.93
|
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:201,915,593...208,479,939
|
|
Q
|
Tcas3
|
Tongue tumor susceptibility QTL 3
|
|
IDA
|
| |
6.88
|
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 4:11,706,604...92,690,519
|
|
Q
|
Tcas4
|
Tongue tumor susceptibility QTL 4
|
|
IDA
|
| |
7.29
|
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr14:17,906,726...54,251,504
|
|
Q
|
Tcas5
|
Tongue tumor susceptibility QTL 5
|
|
IDA
|
| |
10.04
|
|
RGD |
PMID:11429048 |
RGD:634723 |
|
|
Q
|
Tcas6
|
Tongue tumor susceptibility QTL 6
|
|
IDA
|
| |
6.85
|
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 1:102,359,314...153,680,016
|
|
Q
|
Tcas8
|
Tongue tumor susceptibility QTL 8
|
|
IDA
|
| |
3.47
|
|
RGD |
PMID:11429048 |
RGD:634723 |
NCBI chr 5:15,707,451...60,707,451
|
|
Q
|
Tcas9
|
Tongue tumor susceptibility QTL 9
|
|
IDA
|
| |
3.29
|
|
RGD |
PMID:11429048 |
RGD:634723 |
|
|
|
Q
|
Tcat1
|
Tongue tumor resistance QTL 1
|
|
IDA
|
| |
3.3
|
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr 1:108,680,016...153,680,016
|
|
|
Q
|
Emca4
|
Estrogen-induced mammary cancer QTL 4
|
|
IDA
|
| |
3.7
|
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 7:63,889,858...108,889,858
|
|
Q
|
Emca5
|
Estrogen-induced mammary cancer QTL 5
|
|
IDA
|
| |
3.9
|
|
RGD |
PMID:16885383 |
RGD:1642522 |
NCBI chr 3:145,335,553...189,428,310
|
|
|
Q
|
Tls2
|
T-lymphoma susceptibility QTL 2
|
|
IDA
|
| 0.001 |
0.0
|
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr 7:82,111,382...132,099,989
|
|
Q
|
Tls3
|
T-lymphoma susceptibility QTL 3
|
|
IDA
|
| 1.0E-4 |
0.0
|
|
RGD |
PMID:10360666 |
RGD:619600 |
NCBI chr10:27,587,226...96,099,902
|
|
|
Q
|
Tescar1
|
Testicular tumor resistance QTL 1
|
|
IDA
|
| |
3.9
|
|
RGD |
PMID:15805257 |
RGD:1358944 |
NCBI chr11:34,618,760...79,618,760
|
|
|
Q
|
Schws1
|
Schwannoma susceptibility QTL 1
|
|
IDA
|
| 0.0041 |
|
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr10:40,535,708...107,713,808
|
|
Q
|
Schws2
|
Schwannoma susceptibility QTL 2
|
|
IDA
|
| 0.029 |
|
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr 1:153,788,989...198,788,989
|
|
Q
|
Schws3
|
Schwannoma susceptibility QTL 3
|
|
IDA
|
| 0.001 |
|
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr 3:139,299,381...184,299,381
|
|
Q
|
Schws4
|
Schwannoma susceptibility QTL 4
|
|
IDA
|
| 0.0078 |
|
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr 6:78,204,640...123,204,640
|
|
Q
|
Schws7
|
Schwannoma susceptibility QTL 7
|
|
IDA
|
| 0.0115 |
|
|
RGD |
PMID:16003739 |
RGD:1559300 |
|
|
Q
|
Schws8
|
Schwannoma susceptibility QTL 8
|
|
IDA
|
| |
|
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:100,704,576...101,593,851
|
|
Q
|
Schws9
|
Schwannoma susceptibility QTL 9
|
|
IDA
|
| |
|
|
RGD |
PMID:25303613 |
RGD:11566050 |
NCBI chr 6:101,593,607...146,593,607
|
|
|
Q
|
Colcr2
|
Colorectal carcinoma resistance QTL 2
|
|
IDA
|
| 0.0197 |
6.57
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr15:2,315,759...47,315,759
|
|
Q
|
Colcr3
|
Colorectal carcinoma resistance QTL 3
|
|
IDA
|
| 7.0E-6 |
5.02
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:1...25,022,372
|
|
Q
|
Colcr8
|
Colorectal carcinoma resistance QTL 8
|
|
IDA
|
| 0.0014 |
3.1
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:31,990,891...76,990,891
|
|
|
Q
|
Colcr3
|
Colorectal carcinoma resistance QTL 3
|
|
IDA
|
| 7.0E-6 |
5.02
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr18:1...25,022,372
|
|
|
Q
|
Emca1
|
Estrogen-induced mammary cancer QTL 1
|
|
IDA
|
| |
4.4
|
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr 5:104,262,817...153,890,625
|
|
Q
|
Emca10
|
Estrogen-induced mammary cancer QTL 10
|
|
IDA
|
| 0.048 |
|
|
RGD |
PMID:18420736 |
RGD:2292503 |
NCBI chr 6:22,288,257...27,729,050
|
|
Q
|
Emca2
|
Estrogen-induced mammary cancer QTL 2
|
|
IDA
|
| |
1.6
|
|
RGD |
PMID:15611180 |
RGD:1358124 |
NCBI chr18:65,846,447...86,134,022
|
|
Q
|
Mcs26
|
Mammary carcinoma susceptibility QTL 26
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr 6:112,483,610...147,156,653
|
|
Q
|
Mcs27
|
Mammary carcinoma susceptibility QTL 27
|
|
IDA
|
| 1.0E-4 |
|
|
RGD |
PMID:20737482 |
RGD:4143380 |
NCBI chr13:45,990,077...50,392,939
|
|
|
Q
|
Tls1
|
T-lymphoma susceptibility QTL 1
|
|
IDA
|
| 0.001 |
0.0
|
|
RGD |
PMID:10360666 |
RGD:619600 |
|
|
|
Q
|
Schws5
|
Schwannoma susceptibility QTL 5
|
|
IDA
|
| 0.0351 |
|
|
RGD |
PMID:16003739 |
RGD:1559300 |
NCBI chr13:64,497,900...109,350,286
|
|
|
Q
|
Tcas7
|
Tongue tumor susceptibility QTL 7
|
|
IDA
|
| 0.001 |
|
|
RGD |
PMID:15876484 |
RGD:1358147 |
NCBI chr19:41,722,546...74,246,245
|
|
|
Q
|
Tcas1
|
Tongue tumor susceptibility QTL 1
|
|
IDA
|
| |
6.08
|
|
RGD |
PMID:9563479 |
RGD:61091 |
NCBI chr19:19,220,689...64,220,689
|
|
|
Q
|
Gcr3
|
Gastric cancer resistance QTL 3
|
|
IDA
|
| |
2.3
|
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,730,818...72,536,785
|
|
|
Q
|
Gcr3
|
Gastric cancer resistance QTL 3
|
|
IDA
|
| |
2.3
|
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr16:17,730,818...72,536,785
|
|
|
Q
|
Gcr1
|
Gastric cancer resistance QTL 1
|
|
IDA
|
| |
2.7
|
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 4:103,834,277...148,834,277
|
|
Q
|
Gcr2
|
Gastric cancer resistance QTL 2
|
|
IDA
|
| |
2.6
|
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr 3:29,056,275...47,904,329
|
|
Q
|
Gcs1
|
Gastric cancer susceptibility QTL1
|
|
IDA
|
| |
3.8
|
|
RGD |
PMID:10706129 |
RGD:69698 |
NCBI chr15:82,714,037...106,778,197
|
|
|
Q
|
Colcr4
|
Colorectal carcinoma resistance QTL4
|
|
IDA
|
| 7.0E-4 |
3.71
|
|
RGD |
PMID:17510081 |
RGD:1625309 |
NCBI chr 6:30,937,632...75,937,632
|
|